HIV-1 Reverse Transcriptase Purified from a Recombinant Strain ofEscherichia coli
- 1 June 1990
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 6 (6), 753-764
- https://doi.org/10.1089/aid.1990.6.753
Abstract
A better understanding of the structure and biochemical properties of the replicative machinery of human immunodeficiency virus type 1 (HIV-1) may be useful in the screening and design of drugs that could be used to treat AIDS. We have previously described a recombinant strain of Escherichia coli that produces HIV-1 reverse transcriptase (RT). Fermentation conditions for the large-scale growth of the bacterial strain and a protocol for the purification of an enzymatically active 66-Kd form of the RT have been developed. The purified RT has all of the appropriate enzymatic functions and properties. The recombinant protein can be substituted for the viral enzyme in structural and biochemical studies and used in screens for drugs that could inhibit HIV replication.This publication has 17 references indexed in Scilit:
- Comparison of inhibitory activities of various antiretroviral agents against particle-derived and recombinant human immunodeficiency virus type 1 reverse transcriptasesAntimicrobial Agents and Chemotherapy, 1989
- HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysisBiochemistry, 1988
- Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.Proceedings of the National Academy of Sciences, 1988
- Expression of biologically active human T-cell lymphotropic virus type III reverse transcriptase in Bacillus subtilisGene, 1987
- RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virus.Journal of Biological Chemistry, 1987
- Expression and Processing of the AIDS Virus Reverse Transcriptase in Escherichia coliScience, 1987
- Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proceedings of the National Academy of Sciences, 1986
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985